Expected Outcome:
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Staying healthy in a rapidly changing society”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:
Scope:
Life science innovations significantly contribute to peoples’ daily life and to individual and social well-being. To foster public trust, people must understand how life sciences work and how these technologies may impact people’s lives.
This trust is not guaranteed. It is increasingly threatened by the rapid spread of mis- and disinformation and by insufficient outreach to and involvement of people to address their concerns and expectations. To maintain and deepen trust, especially among young people, R&I policymakers, researchers and industry players must be better equipped to engage with the public and to pursue responsible research and innovation.
Citizen engagement is particularly critical in areas like agriculture and food technology, where innovation intersects with health and sustainability considerations and values. Furthermore, citizen participation is key to build trust in the life sciences and ensure that they meet societal needs. By engaging citizens early on, we can ensure that research and innovation align with their values, concerns and expectations. This involves designing research and innovation processes that incorporate citizen input, such as setting research priorities, and create outcomes that are responsive to their needs.
To this end, proposals should address all the following activities:
Regarding advisory support and training, proposals should present how they will engage bilaterally with life science stakeholders to advise them and train them on science communication and risk communication in the life sciences. The proposal selected for funding should also establish links with the European Competence Centre for Science Communication[1] currently being created by the COALESCE[2] project and expected to be launched in 2027[3].
Regarding engagement of citizens in the development, co-production and co-design of life sciences innovations, proposals should focus on advising and training life science actors in deliberative citizen participation and co-design with citizens, including tools that allow discussions about values and ethical considerations of innovations in this sector. Proposals should set out the ways in which they will support life science actors to involve citizens in co-design, and also set out how they will evaluate the impact of the citizen engagement activities that they have supported. The consortium selected for funding is encouraged to use the tools and methods developed under previous research and tailor them to the life sciences.
Regarding the repository of tools and support for risk communication, such tools already exist and have been developed, notably the EU funded projects listed in the CORDIS Results Pack “Science communication: Empowering citizens in the public discussion of science”[4], the CORDIS Results Pack “Ethics and integrity: Building bridges for trust and excellence in research and innovation”[5] and the World Health Organization (WHO) guidelines for emergency risk communication[6]. Proposals should present what tools they will gather, how they will publish them, and what publicity and outreach they will conduct to raise awareness of this repository among the relevant life science actors (policymakers, researchers, industry, civil society organisations), tailoring tools and trainings to the life sciences. Proposals should present a long-term strategy for how the repository of tools will continue to be accessible beyond the lifecycle of this Coordination and Support Action (CSA).
Regarding community engagement activities, proposals should experiment with new and engaging formats across the programmed activities. Proposals should promote both science education, and multiple forms of public engagement with science, focusing on the life sciences. Proposals should focus on any areas within the life sciences, but at least one community engagement activity should focus on agriculture and food technology. The consortium selected for funding is encouraged to make use of findings and tools for stakeholder engagement developed by other Horizon Europe projects, including projects funded under topic HORIZON-CL6-2023-GOVERNANCE-01-6: “Co-creation and trust-building measures for biotechnology and bio-based innovation systems”. The consortium selected for funding is also encouraged to establish links with the projects funded under topic HORIZON-WIDERA-2026-07-ERA-05: “Pillar III: Fostering citizen engagement for more responsible and democratic R&I”, that will develop tools and guidelines on public engagement in R&I, and to tailor these tools and guidelines to applications in the life sciences. Proposals should explain how they will partner with relevant local actors, such as science museums, R&I organisations, and/or community organisations, to run innovative community engagement activities on the life sciences.
Proposals may consider involving the European Commission's Joint Research Centre (JRC) to participate in the advisory board of the consortium selected for funding, notably to benefit from the expertise of the JRC's Competence Centre on Participatory and Deliberative Democracy[7], regarding the engagement of citizens in the design of life sciences innovations and community engagement activities. Any such collaboration should be established after the proposal’s approval.
The EC is impact-driven: proposals must show how the project will:
Solve a major European or global societal challenge
Deliver measurable, lasting benefits for EU citizens
Produce outputs that can be used by policymakers, industry, or society
Align with Horizon Europe missions, priorities, and strategic agendas
Predictor: Clear, quantifiable, EU-level impact → strongest scoring factor.
Successful proposals show:
2–4 well-defined objectives linked to the Work Programme call text
Clearly articulated research questions or innovation goals
Logical, realistic expected outcomes and deliverables
Feasible scientific and technical approaches
Predictor: Balanced ambition + feasibility.
For RIA/IA/CSA or ERC-level grants, reviewers expect:
High novelty and innovation
Strong grounding in current state-of-the-art
Clear advancement beyond existing approaches
Solid theoretical or experimental foundations
Robust methodological design
Predictor: Scientific excellence is essential for competitive scoring.
EC proposals are consortium-driven (except ERC/EIC Accelerator).
High-scoring consortia:
Cover all needed competencies (science, industry, policy, ethics, dissemination)
Include SMEs, industry partners, NGOs, and public bodies when relevant
Are geographically diverse across EU Member States and Associated Countries
Demonstrate strong leadership and communication structures
Predictor: Well-constructed consortium with clear roles.
Evaluators look for a credible trajectory showing:
How research leads to specific outputs (data, tools, prototypes)
How outputs lead to uptake or use
How use produces societal, economic, scientific, or policy impact
Strong Key Performance Indicators (KPIs) and impact metrics
Predictor: Clearly mapped impact pathway.
Winning proposals have:
Well-designed Work Packages (WPs) with clear scope and responsibilities
Interdependencies identified and risk-mitigation strategies
Detailed milestones and deliverables
Feasible budget aligned with tasks
Strong project management plan
Predictor: High implementation quality boosts the “Excellence” and “Implementation” scores.
Especially critical for health, climate, digital, and social calls.
Proposals score higher when they link to:
EU Cancer Mission
EU Green Deal
Digital Europe strategy
EU Biodiversity Strategy
EU Health Union & One Health
Open Science & FAIR data mandates
Predictor: Clear alignment with EU policies.
EC values inclusivity:
Patient groups
Civil society organizations
Public sector bodies
Regulatory agencies
Citizen science components
Stakeholder letters of intent or commitment strengthen credibility.
Predictor: Engagement adds impact and relevance.
Mandatory components include:
FAIR Data Management Plan
Open access publications
Ethics self-assessment
GDPR compliance
Data security, governance, and ethical approvals
Animal-use reduction and justification (if applicable)
Predictor: Clear compliance with ethical and data obligations.
Budget must be:
Proportional to tasks
Transparent and reasonable
Efficiently distributed among partners
Free from padding or unjustified costs
Predictor: Realistic budgets improve Implementation scores.
| Pitfall | Why It Fails |
|---|---|
| Weak connection to Work Programme text | Immediate score reduction |
| Vague or generic impact statements | Poor Impact score |
| Overly ambitious, unrealistic scope | Feasibility concerns |
| Poorly structured consortium | Low Implementation score |
| No policy relevance | Weak strategic alignment |
| Lack of concrete KPIs or outcomes | Impact unclear |
| Weak data or ethics plan | Eligibility/score penalties |
| No exploitation or dissemination plan | Insufficient impact credibility |
| Budget misalignment | Reviewer distrust |
Eligible Countries
Eligible countries are described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
Other Eligibility Conditions
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, legal entities established in the United States of America may exceptionally participate as a beneficiary or affiliated entity, and are eligible to receive Union funding.
Coordinators of projects must be legal entities established in an EU Member State or Associated Country.
If projects use satellite-based earth observation, positioning, navigation and/or related timing data and services, beneficiaries must make use of Copernicus and/or Galileo/EGNOS (other data and services may additionally be used).
The Joint Research Centre (JRC) may participate as member of the consortium selected for funding as a beneficiary with zero funding, or as an associated partner. The JRC will not participate in the preparation and submission of the proposal - see General Annex B.
Sponsor Institute/Organizations: European Commission
Sponsor Type: Corporate/Non-Profit
Address: Rue de la Loi 200 / Wetstraat 200, 1049 Brussels, Belgium.
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Apr 16, 2026
Apr 16, 2026
$2,242,000
€1.9 million
Affiliation: European Commission
Address: Rue de la Loi 200 / Wetstraat 200, 1049 Brussels, Belgium.
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.